Viewing Study NCT06401005


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2025-12-26 @ 2:12 AM
Study NCT ID: NCT06401005
Status: RECRUITING
Last Update Posted: 2024-12-02
First Post: 2024-04-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)
Sponsor: Hubei Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module